Search results

Narrow your search

Result types

Showing 891 - 900 of 1738 for "Makes & Partners" with applied filters

News & Analysis

Anatomy of Licensing Deals from China Regulatory Perspective

04 January 2024 by Aaron GU, Pengfei YOU, Duzhiyun ZHENG, Yuzhen ZHANG, Fengqi YU

Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.

News & Analysis

Sponsored briefing: The foreign acquisition of Chinese enterprises

03 January 2024 by Hui Ye Law Firm - China

Wu Dong of Hui Ye Law Firm discusses the key points necessary for understanding the foreign acquisition of Chinese state-owned enterprises

News & Analysis

Foreign Acquisition of Chinese State-Owned Enterprises

03 January 2024 by Hui Ye Law Firm - China

Wu Dong and Sun Xiaoning from Hui Ye Law Firm highlight a number of considerations that warrant particular attention from foreign investors seeking to acquire state-owned enterprises in China.

News & Analysis

“Known Substance” Must be Disclosed Before the Date of Priority for Section 3(d) of Patents Act: Madras High Court

02 January 2024 by Manisha Singh (Partner) & Avi Garg (Partner)

Non-patentable inventions are always a bone of contention between the applicant and the patent office.

News & Analysis

Roche v DCGI: Delhi High Court on Rejection of Plaints and Doctrine of Passing Off

21 December 2023 by Manisha Singh (Partner) & Neha Ruhela (Senior Associate)

The Delhi High Court, in F Hoffmann-La Roche & others v. Drugs Controller General of India & others (2023:DHC:6522), dismissed applications filed by Cadila Healthcare and Hetero Drugs seeking rejection of the plaints in Roche’s suits

News & Analysis

VILAF announces promotion of new partner Tung Nguyen

15 December 2023 by VILAF - Vietnam

VILAF announces promotion of new partner Tung Nguyen

News & Analysis

Designing around patent is considered legitimate

13 December 2023 by DPS Parmar

It is common to find competitive inventors to work on the uncovered aspect of a patent claim and design around it to escape the sword of infringement.

News & Analysis

Shareholders’ Contractual Rights in Korea’s Rehabilitation Proceedings

04 December 2023 by Jipyong - South Korea

In a recent case concerning shareholders’ contractual rights in rehabilitation proceedings, Korea’s Supreme Court held that a contract which grants the shareholders the right to consent

News & Analysis

LexOrbis Strengthens its IP Footprint with Chennai Expansion

04 December 2023 by LexOrbis - India

LexOrbis is delighted to announce the opening of its new office in Chennai, India.

News & Analysis

Effects of the Draft Patent Rules, 2023 on Pharma Industry

30 November 2023 by Manisha Singh (Partner) & Harshini A. (Trainee Associate)

A couple of months back, the Ministry of Commerce and Industry published the Draft Patents (Amendment) Rules,2023, with various changes to the rules, regulations and fees, which welcomed suggestions and objections from the public.